Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, Q1 2013 - Q1 2014
2013 ^ 2014 ^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 271 273 316 290 276
20 - 44 3,515 3,263 3,173 3,382 3,573
45 - 64 12,065 11,392 10,797 11,410 11,869
65 - 74 7,736 7,475 7,021 7,325 7,825
75 + 7,315 6,931 6,630 6,768 7,256
Male 17,942 16,868 16,034 16,896 17,930
Female 12,960 12,466 11,903 12,279 12,869
Diabetes 13,723 13,079 12,016 12,653 13,333
Hypertension 8,951 8,547 7,996 8,192 8,242
Glomerulonephritis 2,399 2,141 2,140 2,156 2,206
Cystic Kidney 640 620 636 589 641
Other Urologic 360 351 357 311 366
Other Cause 2,802 2,687 2,558 2,658 2,577
Unknown Cause 1,048 1,004 990 1,243 1,843
Missing Cause 979 905 1,244 1,373 1,591
All 30,902 29,334 27,937 29,175 30,799

^ Data as of June 30, 2014
* Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.
Point prevalent counts of reported ESRD, 2013 - 2014/1Q
2013 ^ 2014 ^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 7,550 7,540 7,532 7,561 7,563
20 - 44 103,244 103,523 103,608 103,740 104,137
45 - 64 287,340 289,933 291,623 293,911 296,066
65 - 74 143,222 145,691 148,167 150,663 153,213
75 + 105,103 106,486 108,102 109,389 110,872
Male 369,689 373,769 377,328 381,157 385,427
Female 276,676 279,315 281,616 284,018 286,337
Diabetes 242,211 244,944 246,992 249,170 251,399
Hypertension 161,034 163,287 165,162 166,995 168,652
Glomerulonephritis 106,968 107,477 108,026 108,559 109,067
Cystic kidney 30,338 30,612 30,885 31,123 31,366
Other urologic 11,137 11,164 11,214 11,226 11,294
Other cause 56,781 57,220 57,539 57,951 58,136
Unknown cause 29,289 29,395 29,527 29,926 30,814
Missing disease 8,701 9,074 9,687 10,314 11,123
All 646,459 653,173 659,032 665,264 671,851

^ Data as of June 30, 2014.
* Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2013/1Q - 2014/1Q
2013 ^ 2014 ^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
White 19,801 18,832 17,655 18,156 18,718
Black/African American 8,142 7,675 7,178 7,586 7,702
Native American/Alaska Native 302 271 246 301 275
Asian 1,212 1,114 1,033 1,063 1,175
Pacific Islander 298 333 316 307 330
Other/Unknown * * * 19 42
No ME Form 1,148 1,108 1,513 1,751 2,568
Hispanic 4,259 4,015 3,649 3,917 4,068
Non-Hispanic 25,498 24,210 22,780 23,505 24,152
Unknown * * * * 22
No ME Form 1,148 1,108 1,513 1,751 2,568
Hemodialysis (%)1 91.6 90.5 89.7 90 90.5
CAPD (%)1 4.1 4.5 4.9 4.5 3.1
CCPD (%)1 4.2 4.8 5.1 5 5.2
Other (%)1 0.1 0.2 0.2 0.4 1.2
Cathether Only (%)2 60.6 59.2 59.1 60.7 60.8
Catheter w/ maturing AVF (%)2 18.3 18.4 17.8 17.4 17.1
Catheter w/ maturing AVG (%)2 2.0 2.0 1.9 1.9 1.8
AVF (%)2 16.3 17.0 17.8 16.7 16.6
AVG (%)2 2.5 3.0 3.0 2.9 2.6
Other(%)2 0.1 0.2 0.1 0.1 0.1
Unknown(%)2 0.2 0.2 0.2 0.4 0.9
Pre-ESRD EPO(% Yes)3 15.1 15.3 15.1 14.3 11.2
Pre-ESRD Nephrology(% Yes)3 69.6 71.3 71.9 71 70.4
Mean Serum Albumin(g/dL)4 3.2 3.2 3.3 3.3 3.2
Mean Serum Creatinine(mg/dL)4 6.7 6.5 6.6 6.6 6.7
Mean Hemoglobin(g/dL)4 9.7 9.6 9.7 9.6 9.5
All 30,902 29,334 27,937 29,175 30,799
All with ME Form 29,760 28,229 26,431 27,432 28,242
Dialysis Pts with ME Form 29,166 27,652 25,795 26,799 27,707
Hemodialysis Pts w/ ME Form 26,715 25,020 23,144 24,131 25,073

^ Data as of June 30, 2014.
* Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator "Dialysis Patients with ME Form" counts.
2 Vascular access type percentages shown are based on denominator "Hemodialysis Patients with ME Form" counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. "Did patient receive exogenous erythropoetin or equivalent?"
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. "Was patient under care of nephrologist?"
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator "All with ME Form" counts.
4 Mean laboratory test values shown are based on denominator "All with ME Form" counts.